Analyst consensus rating
Microbot Medical Analyst Rating: Strong Buy
MBOT is rated Strong Buy by 3 analysts with a $6.67 target. As of 2026-09-02.
Direct answer
Microbot Medical's consensus rating is Strong Buy.
3 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $6.67.
Forecast evidence checked September 2, 2026.
Get free Microbot Medical email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $1.48
- Average price target
- $6.67
- High price target
- $12.00
- Low price target
- $4.00
- Low target gap
- +171.2%
- Target upside
- +352%
- High target gap
- +713.6%
- Target range width
- 542.4%
- Consensus rating
- Strong Buy
- Analysts
- 3
- Evidence date
- September 2, 2026
- Valid through
- September 9, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Microbot Medical?
Microbot Medical has a verified Strong Buy consensus. The same dataset has an average price target of $6.67.
How far are Microbot Medical's low and high targets from the recorded price?
The low target implies +171.2%, while the high target implies +713.6%.
How many analysts are included in Microbot Medical's consensus?
The verified consensus includes 3 analysts.
How is Microbot Medical's target upside or downside calculated?
The average target of $6.67 is divided by the recorded price of $1.48, then one is subtracted to produce +352%. This does not guarantee a future return.
When was Microbot Medical's analyst forecast verified?
The data was verified on 2026-09-02. The dataset is valid through 2026-09-09.